Cystic fibrosis testing comes of age

Journal of Molecular Diagnostics

Volumn 11, Issue 3, 2009, Pages 173-175

  Grody, Wayne W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CLINICAL PRACTICE; CTFR GENE; CYSTIC FIBROSIS; DNA HYBRIDIZATION; DNA PROBE; DNA SEQUENCE; GENE; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HOMOZYGOSITY; HUMAN; NOTE; OUTCOME ASSESSMENT; PHENOTYPE; PRACTICE GUIDELINE; PRENATAL CARE; SITE DIRECTED MUTAGENESIS; ALLELE; EDITORIAL; GENETIC SCREENING; GENETICS; MUTATION;

ALLELES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENETIC SCREENING; HUMANS; MUTATION;

EID: 67149096688     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2009.090024     Document Type: Note

References (18)

1. Grody WW, Cutting G, Klinger K, Richards CS, Watson MS, Desnick RJ: Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001, 3:149-154
2. Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA: American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 2001, 3:139-148
3. Witt D, Wold C, Goonewardena P, Louie E, Rosenfeld S: Cystic fibrosis screening of 103,600 individuals in an HMO: Molecular/clinical outcomes and a dramatic reduction in CF incidence. (Abstract) Annual Meeting, American Society of Human Genetics, Baltimore, 2008, 160
4. Hale JE, Parad RB, Comeau AM: Newborn screening showing decreasing incidence of cystic fibrosis. N Engl J Med 2008, 358: 973-974
5. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs E, Strom CM, Richards CS, Witt DR, Grody WW: Cystic fibrosis population carrier screening: 2004 revision of the American College of Medical Genetics mutation panel. Genet Med 2004, 6:387-391
6. Grody WW, Cutting G. and Watson MS: The cystic fibrosis mutation "arms race": when less is more. Genet Med 2007, 9:739-744
7. Lebo RV, Bixler M, Galehouse D: One multiplex control for 29 cystic fibrosis mutations. Genet Test 2007, 11:256-268
8. Sebastian S, Spitzer SG, Grosso LE, Amos J, Schaefer FV, Lyon E, Wolff DJ, Hajianpour A, Taylor AK, Millson A, Stenzel TT: Multicenter characterization and validation of the intron-8 poly(T) tract (IVS8-T) status in 25 Coriell cell repository cystic fibrosis reference cell lines for cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation assays. Clin Chem 2004, 50:251-254
9. Grody WW: Quest for controls in molecular genetics. J Mol Diagn 2003, 5:209-211
10. Berwouts S, Gordon JT, Rundell CA, Barton DE, Dequeker E: Evaluation and use of a synthetic quality control material, included in the European external quality assessment scheme for cystic fibrosis. Hum Mutat 2008, 29:1063-1070
11. Pratt VM, Caggana M, Bridges C, Buller AM, DiAntonio L, Highsmith WE, Holtegaard LM, Muralidharan K, Rohlfs EM, Tarleton J, Toji L, Barker SD, Kalman LV: Development of genomic reference materials for cystic fibrosis testing. J Mol Diagn 2009, 11:186-193
12. Alper OM, Wong LJ, Young S, Pearl M, Graham S, Sherwin J, Nussbaum E, Nielson D, Platzker A, Davies Z, Lieberthal A, Chin T, Shay G, Hardy K, Kharrazi M: Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients. Hum Mutat 2004, 24:353
13. Heim RA, Sugarman EA, Allitto BA: Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel. Genet Med 2001, 3:168-176
14. Schwartz KM, Pike-Buchanan LL, Muralidharan K, Redman JB, Wilson JA, Jarvis M, Cura MG, Pratt VM: Identification of cystic fibrosis (CF) variants by PCR/oligonucleotide ligation (OLA) assay. J Mol Diagn 2009, 11:211-215
15. Hantash FM, Rebuyon A, Peng M, Redman JB, Sun W, Strom CM: Apparent homozygosity of a novel frame shift mutation in the CFTRA gene because of a large deletion. J Mol Diagn 2009, 11:253-254
16. Rohlfs EM, Chung CH, Yang Q, Skrzynia C, Grody WW, Graham ML, Silverman LM: In-frame deletions of BRCA1 may define critical functional domains. Hum Genet 2000, 107:385-390
17. Hantash FM, Redman JB, Starn K, Anderson B, Buller A, McGinniss MJ, Quan F, Peng M, Sun W, Strom CM: Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening. Hum Genet 2006, 119:126-136
18. Chevalier-Porst F, Bonardot AM, Chazalette JP, Mathieu M, Bozon D: 40 kilobase deletion (CF 40 kb del 4-10) removes exons 4 to 10 of the cystic fibrosis transmembrane conductance regulator gene. Hum Mutat 1998, Suppl 1:S291-S294